Linc
83.9
SEK
-1.18 %
LINC
NASDAQ Stockholm
Investment
Financials
Be the first to follow this company
-1.18%
+8.82%
-4.88%
-4.66%
+29.88%
+24.3%
-9.75%
-
-1.29%
Linc is an investment company. The company specializes in investment, ownership, and further management of companies in the Life Science industry. The investments are mainly made in small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals. The vision is to be an active and long-term owner. The largest share of investments takes place in the Nordic region.
Read moreMarket cap
4.86B SEK
Turnover
2.88M SEK
Revenue
-
EBIT %
-
P/E
7.84
Dividend yield-%
-
Financial calendar
23.1
2025
Annual report '24
23.4
2025
Interim report Q1'25
17.7
2025
Interim report Q2'25
ShowingAll content types
Offering price for Linc’s initial public offering set at SEK 67 per share – trading on Nasdaq Stockholm commences tomorrow
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools